| Thursday 20 November - Day one | |
| 10.30am | Registration, welcome refreshments, exhibition and poster viewing |
| 11.00am | Chair's welcome and introduction Dr Chris Dean, Lead Stereotactic Radiotherapy Physicist, Barts Health NHS Trust & Vice-Chair, UK SABR Consortium |
| 11.05am | Specialised commissioning for Radiotherapy Dr Imogen Locke, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust |
| 11.25am | Keynote address Professor Clifford G. Robinson, Professor of Radiation Oncology Chief, Stereotactic Body Radiation Therapy (SBRT) Associate Director, Clinical Programs, Washington University School of Medicine, St Louis, USA |
| 12.00pm | Sponsored session supported by Elekta Speaker tba |
| 12.30pm | SABR QA Programme and trials update Patricia Diez, Lead Clinical Scientist, RTTQA and Dr Rushil Patel, Lead SABR Physicist, RTTQA, Mount Vernon Cancer Centre |
| 1.00pm | Lunch, exhibition and poster viewing |
| 2.10pm | The integration of Artificial Intelligence in the SABR pathway Matthew Clarke, Consultant Clinical Scientist, Radiotherapy Physics Group Leader, The Christie NHS Foundation Trust |
| 2.40pm | Proffered papers in the spotlight - a selection of the best submitted abstracts |
| 3.20pm | Refreshments, exhibition and poster viewing |
| 4.00pm | The Great British SABR MDT Expert panel: Professor Clifford G. Robinson, Dr Stephen J Harrow, Consultant Clinical Oncologist Thoracic Malignancies & OMD, Edinburgh Cancer Centre, Dr Aidan Cole, Consultant Clinical Oncologist, Belfast Health and Social Care Trust, Marina Khan, Research & Development Lead Radiographer, Guys and St Thomas’ NHS Foundation Trust & Joe Flaherty Clinical Technologist – Treatment Planning Team Lead, University Hospitals Bristol and Weston NHS Foundation |
| 5.00pm | Hybrid radiotherapy for phase III lung cancer Professor Gerry Hanna, Trinity College Dublin, Consultant in Radiation Oncology, St Luke's Radiation Oncology Network |
| 5.30pm | Closing remarks |
| 7.30pm | UK SABR Consortium Annual Conference Dinner Hilton Hotel, Newcastle, Gateshead |
| Friday 21 November - Day two | |
| 8.30am | Registration, welcome refreshments, exhibition and poster viewing |
| 8.55am | Chair's introduction Dr Rebecca Muirhead, Consultant Clinical Oncologist, Oxford University NHS Foundation Trust & Vice-Chair, UK SABR Consortium |
| 9.00am | FLAME Trial - boosting prostate patients Professor Uulke Van der Heide, Group leader, Professor at Leiden UMC |
| 9.30am | Oligometastatic prostate cancer
|
| 10.30am | Adaptive radiotherapy Speaker tba |
| 11.00am | Refreshments, exhibition and poster viewing |
| 11.30am | Dose accumulation in the context of reirradiation Eliana Vasquez Osorio, Senior Research Fellow, The University of Manchester |
| 12.00pm | Sponsored session Speaker tba |
| 12.30pm | Proffered papers in the spotlight - a selection of the best submitted abstracts |
| 1.20pm | Lunch, final exhibition and poster viewing |
| 2.20pm | Considerations for treating oligometastases in colorectal cancer Dr Nicos Fotiadis, Consultant Interventional Radiologist, The Royal Marsden NHS Foundation Trust, Dr Katharine Aitken, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust & Dr Rebecca Muirhead |
| 3.00pm | UK SABR Consortium's Dragon's Den Expert Panel: Chairs: Patricia Diez & Dr Aidan Cole Professor Gerry Hanna, Professor Emma Hall, Professor in Oncology Clinical Trials, The Institute of Cancer Research, Dr Ganesh Radhakrishna, Clinical Oncologist, The Christie NHS Foundation Trust, Dr Alison Tree & Professor Clifford G. Robinson |
| 3.45pm | Closing remarks |